A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria.

● Data from the identified articles were evaluated for fulfillment of the following criteria: literature review, clinician input, concept elicitation with patients, achievement of saturation, content validity of items assessed with patients, recall period validated with patients, response options validated with patients, item tracking matrix, conceptual framework, internal consistency reliability, test-retest reliability, convergent validity, known groups validity, and ability to detect change.